MSB 2.08% 94.0¢ mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-381

  1. 5,344 Posts.
    lightbulb Created with Sketch. 957
    Timmy and others who post on vrs37 , He/She has a degree in oncology and gastroenterology medicine And my guess views Stem cells as an alternative medicine , not what he/she spent many years studying, which I can understand . Change is always looked upon as the inferior method but we must move with it to improve the new technology for the better and in this case change the paradigm of medicine , which is going to happen ...
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.